Dallah Healthcare Co

Last Updated:
  • 101.50 SAR
  • 1.00
  • 1.00%
شركة دله للخدمات الصحية
دله الصحية
Symbol : 4004
ISIN : SA135G51UI10
Day Range : -
Turnover Ratio : 0.25
Market : Saudi Exchange
Sector : Health Care Equipment & Svc
Latest Announcements
2026-08-20 12:46:00.0Dallah Healthcare Company Announces the Resignation of the Chief Executive Officer and the Appointment of an Acting Chief Executive Officer
2026-08-05 05:18:00.0Dallah Healthcare Co. calls its shareholders to attend the Extraordinary General Assembly meeting which include the Increase of the company’s capital ( First Meeting ) via Modern Technology Means
2026-08-04 05:14:00.0Dallah Healthcare Company announces the Board of Directors’ decision to distribute interim cash dividends to shareholders for the second quarter of 2026.
2026-08-04 05:11:00.0Dallah Healthcare Co. announces its Interim Financial results for the Period Ending on 2026-06-30 ( Six Months )
2026-07-21 05:08:00.0Dallah Healthcare Company announces recent developments related to the sale of its shares in Dr. Mohammed Bin Rashed Al Fagih & Partners Company for a value of SAR 497,983,407

Dallah Healthcare Co Stock Overview

View Company Profile

Stock Summary

Last Price (SAR) 101.50
Prev. Close 100.500
Day Range 100.70 - 101.70
52WK range
Turnover (M SAR) 6.45
Volume (M) 0.06
Number of Trades 795
Market Cap (M SAR) 10,309.84
Change in Market Cap (M SAR)
VWAP (SAR) 0.00
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M SAR)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
30-Aug-2026 Reviewing Agenda Items

Riyadh – Mubasher: Dallah Healthcare Company’s board of directors has accepted the resignation of CEO Ahmed bin Saleh Babaeer, effective 1...

Riyadh – Mubasher: The board of Dallah Healthcare Company approved a cash dividend distribution of SAR 50.40 million for the second quarter (Q2)...

Riyadh – Mubasher: Dallah Healthcare Company announced its preliminary financial results for the first half (H1) of 2026, reporting a net profit...

Riyadh – Mubasher: Dallah Healthcare Company has completed the sale of its entire 31.21% stake in Dr. Mohammed bin Rashid Al Faqih and Partners.The...

Riyadh – Mubasher: The Capital Market Authority (CMA) has granted approval for Dallah Healthcare Company to increase its capital from SAR 1.01 billion...